Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beam Therapeutics Inc. Director's Dealing 2021

Aug 26, 2021

31533_dirs_2021-08-26_5f353838-d26f-4b62-b076-8c044030dc9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-08-24

Reporting Person: FMR LLC (See Remark 1)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-24 Common Stock J 1615314 Disposed 4611205 Indirect
2021-08-24 Common Stock J 16153 Acquired 16153 Indirect
2021-08-24 Common Stock J 16153 Disposed 0 Indirect
2021-08-24 Common Stock J 1569 Acquired 2293 Indirect
2021-08-24 Common Stock J 969189 Acquired 969342 Indirect
2021-08-25 Common Stock J 969038 Disposed 304 Indirect
2021-08-25 Common Stock J 793736 Acquired 1744221 Indirect

Footnotes

F1: These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.